RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Enhanced Bioavailability of Paclitaxel by Bamboo Concentrate Administration

      한글로보기

      https://www.riss.kr/link?id=A104668077

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The purpose of this study was to investigate the effect of a cotreatment of bamboo concentrates (Jukcho solution; 0.75, 1.5, and 3.0 mL/kg) with the chemotherapeutic agent paclitaxel on the bioavailability of orally administered paclitaxel (50 mg/kg) ...

      The purpose of this study was to investigate the effect of a cotreatment of bamboo concentrates (Jukcho solution; 0.75, 1.5, and 3.0 mL/kg) with the chemotherapeutic agent paclitaxel on the bioavailability of orally administered paclitaxel (50 mg/kg) in rats. The effect of a pretreatment of bamboo concentrates (1.5 and 3.0 mL/kg for 1.0 h or a consecutive 3 day) was also examined. The paclitaxel plasma concentrations of rats orally administered paclitaxel plus bamboo concentrates (coadministration, 3.0 mL/kg and pretreatment, 1.5 and 3.0 mL/kg) were significantly higher than those of rats treated with paclitaxel alone. Plasma concentrations of paclitaxel in groups pretreated with bamboo concentrates for 3 day were markedly higher than those of a paclitaxel control group at the measured time points. The areas under plasma concentration- time curves (AUCs) of paclitaxel in groups pretreated with bamboo concentrates were elevated and the absolute bioavailability (AB%) and relative bioavailability (RB%) of paclitaxel were also significantly higher than those in the control group. The peak concentration (Cmax), half-life (t1/2), and the elimination rate constant (Kel) of paclitaxel after 3 day of pretreatment with bamboo concentrates were also significantly higher than those in the control, but the time required to reach the maximum plasma concentration (Tmax) of paclitaxel was unaffected by the bamboo concentrates. Western blot analyses demonstrated that the level of CYP3A4 was increased in the livers of rats treated orally with paclitaxel, but this was reversed by pretreating with bamboo concentrates. These results show that bamboo concentrates enhance the bioavailability of orally administered paclitaxel and this effect may be associated with a diminished expression of CYP3A4 in the liver.

      더보기

      참고문헌 (Reference)

      1 "in biologicalfluids by high performance liquid chromatography. YakugakuZasshi" and naka (and naka): 351-355, 1994

      2 "Variability in human cytochrome P450paclitaxel metabolism. J. Pharmacol. Exp. Ther." Sonnichsen 275 : 566-575, 1995

      3 "The barrier function of CYP3A4 and Pglycoproteinin the small bowel. Adv. Drug Deliv. Rev." 27 : 161-170, 1996

      4 "Taxol-induced polymerization of purified tubulin.Mechanism of action. J. Biol. Chem." 10435-10441, 1981

      5 "Taxol metabolism by human liver microsomes Identification of cytochrome P450 isozymes involvedin its biotransformation. Cancer Res." 386-392, 1994

      6 "Studies on search for apromising immunopotentiative substance for treatment ofleprosy. Analytical studies on bamboo grass. Nippon RaiGakkai Zasshi" 38-46, 1980

      7 "Selective biotransformation of taxol to 6㈅ -hydroxytaxol by human cytochrome P450 2C8. Cancer Res." 5543-5546, 1994

      8 "Rapid and sensitivedetermination of paclitaxel in mouse plasma by high-performanceliquid chromatography. J. Chomatogr. B" 724 : 357-363, 1999

      9 "Phase II trial of taxol an active drug in thetreatment of metastatic breast cancer. J. Natl. Cancer Inst." 1797-1805, 1991

      10 "Phase I study of taxol and granulocyte colony-stimulatingfactor in patients with refractory ovarian cancer. J. Clin.Oncol." 1165-1170, 1992

      1 "in biologicalfluids by high performance liquid chromatography. YakugakuZasshi" and naka (and naka): 351-355, 1994

      2 "Variability in human cytochrome P450paclitaxel metabolism. J. Pharmacol. Exp. Ther." Sonnichsen 275 : 566-575, 1995

      3 "The barrier function of CYP3A4 and Pglycoproteinin the small bowel. Adv. Drug Deliv. Rev." 27 : 161-170, 1996

      4 "Taxol-induced polymerization of purified tubulin.Mechanism of action. J. Biol. Chem." 10435-10441, 1981

      5 "Taxol metabolism by human liver microsomes Identification of cytochrome P450 isozymes involvedin its biotransformation. Cancer Res." 386-392, 1994

      6 "Studies on search for apromising immunopotentiative substance for treatment ofleprosy. Analytical studies on bamboo grass. Nippon RaiGakkai Zasshi" 38-46, 1980

      7 "Selective biotransformation of taxol to 6㈅ -hydroxytaxol by human cytochrome P450 2C8. Cancer Res." 5543-5546, 1994

      8 "Rapid and sensitivedetermination of paclitaxel in mouse plasma by high-performanceliquid chromatography. J. Chomatogr. B" 724 : 357-363, 1999

      9 "Phase II trial of taxol an active drug in thetreatment of metastatic breast cancer. J. Natl. Cancer Inst." 1797-1805, 1991

      10 "Phase I study of taxol and granulocyte colony-stimulatingfactor in patients with refractory ovarian cancer. J. Clin.Oncol." 1165-1170, 1992

      11 "Limited oral bioavailability andactive epithelial excretion of paclitaxel caused by Pglycoproteinin the intestine. Proc. Natl. Acad. Sci. USA" 4 : 2031-2035, 1997

      12 "Inhibition of mast celldependentimmediate-type hypersensitivity reactions bypurple bamboo salt. J. Ethnopharmacol." 91 : 153-157, 2004

      13 "Induction of cytochrome P450 3A4 by docetaxel in peripheralmononuclear cells and its expression in lung cancer. CancerChemother. Pharmacol." 48 : 42-46, 2001

      14 "Identification andantioxidant activity of novel chlorogenic acid derivatives frombamboo" 49 : 4646-4655, 2001

      15 "Expression of glutathione StransferasesYa Yc1 and Yc2 and microsomalepoxide hydrolase genes by thiazole" 52 : 1996

      16 "Evaluation of antioxidant andprooxidant activities of bamboo Phyllostachys nigra var.Henonis leaf extract in vitro. J. Agric. Food Chem." 48 : 3170-3176, 2000

      17 "Effects of Sasa Health extract of bamboograss leaves on spontaneous mammary tumourigenesis inSHN mice. Anticancer Res." 18 : 153-158, 1998

      18 "CYP3A-Like cytochrome P450-mediated metabolism andpolarized efflux of cyclosporin A in Caco-2 cells interactionbetween the two biochemical barriers to intestinal transport.Drug Metab. Dispos." 24 : 344-349, 1996

      19 "An antimitotic agent with anew mechanism of action. Pharmacol. Ther." 83-125, 1984

      20 "A unique antineoplasic agent with significant activity inadvanced ovarian epithelial neoplasm. Ann. Intern. Med." 273-279, 1989

      21 "A novel porphyrinphotosensitizer from bamboo leaves that induces apoptosisin cancer cell lines. Anticancer Res." 23 : 2355-2361, 2003

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.96 0.2 1.44
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.07 0.87 0.439 0.05
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼